c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Biohaven stock surges 25% on FDA acceptance of drug filing
Investing.com | Oct 22, 2026 7:13 AM EDT
Read original article